May 17, 2026 by Keith NoonanWhy Poet Technologies Stock Skyrocketed This WeekPoet's new contract announcement powered huge gains for the stock.
May 17, 2026 by Jonathan PoncianoThis Obesity Drug Stock Has Jumped 60% as Phase 3 Plans Advance. A Fund Just Sold $4.7 MillionThis clinical-stage biotech develops oral therapeutics for chronic diseases, with a pipeline centered on metabolic and pulmonary targets.
May 17, 2026 by Matt DiLalloAres Capital's 10% Yield Just Survived a Tough Quarter. Is the BDC Still a Buy?Ares Capital isn't worried about last quarter's challenges.
May 17, 2026 by Jonathan PoncianoAlumis Stock Has Soared 400%. Cormorant Bought Another $8 Million Last QuarterAlumis develops clinical-stage therapies targeting autoimmune and neuroinflammatory diseases through proprietary TYK2 inhibitors.
May 17, 2026 by Jonathan PoncianoWhy This Fund Just Made a $55 Million Bet on Dianthus Amid a 350% Stock RallyThis clinical-stage biotech develops antibody therapies for severe autoimmune diseases, targeting rare neuromuscular conditions.
May 17, 2026 by Ben GranWhy Would Anyone Buy SPYM Instead of QQQ?Buying the S&P 500 instead of the Qs could help you avoid relying too heavily on tech stocks.
May 17, 2026 by Jonathan PoncianoErasca Stock Is Up 715%. Here’s Why One Biotech Fund Still Bought $68 Million MoreThis clinical-stage biotech targets RAS/MAPK pathway cancers with a pipeline of novel small molecule oncology therapies.
May 17, 2026 by Adam LevyMicron's and Sandisk's Futures Are Heavily Influenced by 2 Foreign Chip Companies. Here's How to Buy Them.These memory chipmakers have major expansion plans underway.
May 17, 2026 by John BromelsAI Supercharged This Flatlining U.S. Manufacturing Stock. Now It's Just Scored a Massive New Nvidia Partnership.Corning's stock price has more than doubled this year, and Nvidia could boost it even higher.
May 17, 2026 by Geoffrey SeilerIs Dutch Bros Stock Is a Buy on the Dip as Same-Store Sales Continue to Sizzle?The decline in Dutch Bros stock looks like it could be a great buying opportunity.
May 17, 2026 by Kailey Hagen, CFPHere's Why the New $6,000 Senior Tax Deduction Does Some Retirees No GoodNot everyone qualifies for this sizable tax break.
May 17, 2026 by Jack DelaneyBWXT Stock Is Up Nearly 100% in a Year and Just Announced a Major Acquisition. Is the Nuclear Rally Just Getting Started?Revenue growth isn't explosive, but it's steady because of BWX's nuclear moat.
May 17, 2026 by Rick OrfordOklo's Biggest Opportunity Might Also Be Its Biggest ProblemOklo's nuclear story is getting stronger, but the stock's valuation already prices in a lot of success. Here's what investors need to know.
May 17, 2026 by Lawrence NgaWhy Everyone Is Talking About Lumentum Stock -- and Why Investors Should CareEveryone knows AI needs powerful chips. But what if the next big AI opportunity is actually the technology helping all of those systems communicate with each other?
May 17, 2026 by Reuben Gregg BrewerThis 7.2% Yield Is Safe and On Stronger Ground Than It SeemsConsumer staples makers are dealing with material headwinds, but this one's huge yield looks sustainable.
May 17, 2026 by Christy BieberThe Average American Made a Retirement Savings Mistake It's Hard to Come Back from -- But Not ImpossibleThis retirement savings mistake is a common one, but you can overcome it if you made the error.
May 17, 2026 by Lawrence NgaAlibaba Stock May Be One of the Safest Ways to Play the AI Boom Right NowAI investing often comes with high expectations and high volatility. Alibaba stock offers a different opportunity altogether.
May 17, 2026 by Rick OrfordNavitas vs. Poet: Which AI Infrastructure Stock Is the Better Buy?Two AI infrastructure stocks are surging, but only one has stronger validation. Here's what investors should know before chasing the next move.
May 17, 2026 by Selena MaranjianWhere Will Occidental Petroleum (OXY) Stock Be in 3 Years?It's hard to say, but the company is doing well right now.
May 17, 2026 by Reuben Gregg BrewerCitigroup's Quiet Turnaround: Is the Stock Finally Worth Buying?Shares of Citigroup have risen by more than 60% over the past year, trouncing the performance of many peers.
